Current management of Helicobacter pylori infections in the elderly

Expert Review of Anti-Infective Therapy

Volumn 5, Issue 5, 2007, Pages 845-856

  Salles, Nathalie ^a,b   Mégraud, Francis ^b  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Diagnosis; Elderly; Gastric aging; Helicobacter pylori; Prevalence

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIUM ANTIBODY; BICARBONATE; CAGA PROTEIN; CARBON 13; CHLORIDE; CLARITHROMYCIN; EPIDERMAL GROWTH FACTOR; INTERLEUKIN 1BETA; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROSTAGLANDIN; PROTON PUMP INHIBITOR; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; UREA; UREASE;

ACHLORHYDRIA; AGED; AGING; ALZHEIMER DISEASE; ANTIBIOTIC RESISTANCE; APOPTOSIS; ATROPHIC GASTRITIS; BACTERIAL VIRULENCE; BACTERIUM CULTURE; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG TOLERABILITY; DYSPEPSIA; ELDERLY CARE; ENVIRONMENTAL SANITATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERADICATION THERAPY; FECES ANALYSIS; FOOD INTAKE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GRAM NEGATIVE INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; INSTITUTIONAL CARE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NON INVASIVE MEASUREMENT; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATIENT COMPLIANCE; PEPTIC ULCER; PEPTIC ULCER BLEEDING; PERSONAL HYGIENE; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SEROLOGY; STOMACH ACID SECRETION; STOMACH BIOPSY; STOMACH BLOOD FLOW; STOMACH CANCER; STOMACH CARCINOMA; STOMACH DISEASE; STOMACH ULCER; TREATMENT DURATION; TREATMENT FAILURE; UREA BREATH TEST; WESTERN BLOTTING;

AGE FACTORS; AGED; AGED, 80 AND OVER; APPETITE REGULATION; CLINICAL TRIALS; GASTRIC ACID; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PATIENT COMPLIANCE; PREVALENCE; STOMACH DISEASES;

EID: 35349004160     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.5.5.845     Document Type: Review

References (110)

1. Pilotto A. Aging and upper gastrointestinal disorders. Best Pract. Res. Clin. Gastroenterol. 18(Suppl.), 73-81 (2004).
2. Ofman JJ, Etchason J, Alexander W et al. The quality of care for Medicare patients with peptic ulcer disease. Am. J. Gastroenterol. 95(1), 106-113 (2000).
3. Younger J, Duggan A. Helicobacter pylori infection in elderly patients. Lancet 360(9337), 947-948 (2002).
4. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1(8390), 1311-1315 (1984).
5. Sachs G, Weeks DL, Melchers K, Scott DR. The gastric biology of Helicobacter pylori. Annu. Rev. Physiol. 65, 349-369 (2003).
6. Blaser MJ, Atherton JC. Helicobacter pylori persistence: biology and disease. J. Clin. Invest. 113(3), 321-333 (2004).
7. Akopyants NS, Clifton SW, Kersulyte D et al. Analyses of the cag pathogenicity island of Helicobacter pylori. Mol. Microbiol. 28(1), 37-53 (1998).
8. Parsonnet J, Friedman GD, Orentreich N. Vogelman H. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 40(3), 297-301 (1997).
9. Megraud F. [When and how does Helicobacter pylori infection occur?]. Gastroenterol. Clin. Biol. 27 (3 Pt 2), 374-379 (2003).
10. Nurgalieva ZZ, Malaty HM, Graham DY et al. Helicobacter pylori infection in Kazakhstan: effect of water source and household hygiene. Am. J. Trop. Med. Hyg. 67(2), 201-206 (2002).
11. Regev A, Fraser GM, Braun M, Maoz E, Lelbovici L, Niv Y. Seroprevalence of Helicobacter pylori and length of stay in a nursing home. Helicobacter 4(2), 89-93 (1999).
12. Pilotto A, Fabrello R, Franceschi M et al. Helicobacter pylori infection in asymptomatic elderly subjects living at home or in a nursing home: effects on gastric function and nutritional status. Age Ageing 25(3), 245-249 (1996).
13. Pilotto A. Helicobacter pylori-associated peptic ulcer disease in older patients: current management strategies. Drugs Aging 18(7), 487-494 (2001).
14. Pilotto A, Salles N. Helicobacter pylori infection in geriatrics. Helicobacter 1, 56-62 (2002).
15. Gause-Nilsson I, Gnarpe H, Gnarpe J, Lundborg P, Steen B. Helicobacter pylori serology in elderly people: a 21-year cohort comparison in 70-year-olds and a 20-year longitudinal population study in 70-90-year-olds. Age Ageing 27(4), 433-436 (1998).
16. Salles-Montaudon N, Dertheil S, Broutet N et al. Detecting Helicobacter pylori infection in hospitalized frail older patients: the challenge. J. Am. Geriatr. Soc. 50(10), 1674-1680 (2002).
17. Neri MC, Lai L, Bonetti P et al. Prevalence of Helicobacter pylori infection in elderly inpatients and in institutionalized old people: correlation with nutritional status. Age Ageing 25(1), 17-21 (1996).
18. Torres OH, Munoz J, Ruiz D et al. Outcome predictors of pneumonia in elderly patients: importance of functional assessment. J Am. Geriatr. Soc. 52(10), 1603-1609 (2004).
19. Grossman MI, Kirsner JB, Gillespie IE. Basal and histalog-stimulated gastric secretion in control subjects and in patients with peptic ulcer or gastric cancer. Gastroenterology 45, 14-26 (1963).
20. Baron JH. Studies of basal and peak acid output with an augmented histamine test. Gut 4, 136-144 (1963).
21. Blackman AH, Lambert DL, Thayer WR, Martin HF. Computed normal values for peak acid output based on age, sex and body weight. Am. J. Dig. Dis. 15 (9), 783-789 (1970).
22. Asaka M, Kato M, Kudo M et al. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: studies in asymptomatic Japanese adults. Helicobacter 1(1), 52-56 (1996).
23. Hurwitz A, Brady DA, Schaal SE, Samloff IM, Dedon J, Ruhl CE. Gastric acidity in older adults. JAMA 278(8), 659-662 (1997).
24. Ijima K, Ohara S, Koike T, Sekine H, Shimosegawa T. Gastric acid secretion of normal Japanese subjects in relation to Helicobacter pylori infection, aging, and gender. Scand. J. Gastroenterol. 39(8), 709-716 (2004).
25. Haruma K, Kamada T, Kawaguchi H et al. Effect of age and Helicobacter pylori infection on gastric acid secretion. J. Gastroenterol. Hepatol. 15(3), 277-283 (2000).
26. Greenwald DA. Aging, the gastrointestinal tract, and risk of acid-related disease. Am. J. Med. 117(Suppl. 5A), 8S-13S (2004).
27. Asaka M. Sugiyama T, Nobuta A, Kato M. Takeda H, Graham DY. Atrophic gastritis. and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter 6(4), 294-299 (2001).
28. Sipponen P. Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae. J. Clin. Gastroenterol. 32(3), 196-202 (2001).
29. Zhang C, Yamada N, Wu YL, Wen M, Matsuhisa T, Matsukura N. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer. World J. Gastroenterol. 11(6), 791-796 (2005).
30. Sakaki N, Kozawa H, Egawa N, Tu Y, Sanaka M. Ten-year prospective follow-up study on the relationship between Helicobacter pylori infection and progression of atrophic gastritis, particularly assessed by endoscopic findings. Aliment, Pharmacol. Ther. 16(Suppl. 2), 198-203 (2002).
31. Kokkola A, Kosunen TU, Puolakkainen P et al. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis. APMIS 111(6), 619-624(2003).
32. Malfertheiner P, Megraud F, O'Morain C et al. Current concepts in the management of Helicobacter pyloril infection - the Maastricht 2-2000 Consensus Report. Aliment. Pharmacol. Ther. 16(2), 167-180 (2002).
33. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol. Rev. 78(2), 547-581 (1998).
34. Babior BM. NADPH oxidase: an update. Blood 93(5), 1464-1476 (1999).
35. Krause KH. Tissue distribution and putative physiological function of NOX family NADPH oxidases. Jpn. J. Infect. Dis. 57(5), S28-S29 (2004).
36. Teshima S, Rokutan K, Nikawa T, Kishi K. Guinea pig gastric mucosal cells produce abundant superoxide anion through an NADPH oxidase-like system. Gastroenterology 115(5), 1186-1196 (1998).
37. Teshima S. Tsunawaki S, Rokutan K. Helicobacter pylori lipopolysaccharide enhances the expression of NADPH oxidase components in cultured guinea pig gastric mucosal cells. FEBS Lett. 452(3), 243-246 (1999).
38. Teshima S, Kutsumi H, Kawahara T, Kishi K, Rokutan K. Regulation of growth and apoptosis of cultured guinea pig gastric mucosal cells by mitogenic oxidase 1. Am. J Physiol. Gastrointest. Liver Physiol. 279(6), G1169-G1176 (2000).
39. Salles N, Szanto I, Herrmann F et al. Expression of mRNA for ROS-generating NADPH oxidases in the aging stomach. Exp. Gerontol. 40(4), 353-357 (2005).
40. Naito Y, Yoshikawa T. Molecular and celular mechanisms involved in Helicobacter pylori-induced inflammation and oxidative stress. Free Radic. Biol. Med. 33(3), 323-336 (2002).
41. + Helicobacter pylori strainis. Cancer Res. 61(4), 1406-1411 (2001).
42. Xia HH, Talley NJ. Apoptosis in gastric epithelium induced by Helicobacter pylori infection: Implications in gastric carcinogenesis. Am. J. Gastroenterol. 96(1), 16-26 (2001).
43. Igarashi M, Kitada Y, Yoshiyama H, Takagi A, Miwa T, Koga Y. Ammonia as an accelerator of tumor necrosis factor α-induced apoptosis of gastric epithelial cells in Helicobacter pylori infection. Infect. Immun. 69(2), 816-821 (2001).
44. Lim JW, Kim H, Kim KH. NF-κB, inducible nitric oxide synthase and apoptosis by Helicobacter pylori infection. Free Radic. Biol. Med. 31(3), 355-366 (2001).
45. Newton JL. Changes in upper gastrointestinal physiology with age. Mech. Ageing Dev. 125(12), 867-870 (2004).
46. Newton JL, Jordan N, Pearson J, Williams GV, Allen A, James OF. The adherent gastric antral and duodenal mucus gel layer thins with advancing age in subjects infected with Helicobacter pylori. Gerontology 46(3), 153-157 (2000).
47. Hackelsberger A, Platzer U, Nilius M et al. Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity - independently. Gut 43(4), 465-469 (1998).
48. Cryer B, Redfern JS, Goldschmiedt M, Lee E, Feldman M. Effect of aging on gastric and duodenal mucosal prostaglandin concentrations in humans. Gastroenterology 102(4 Pt 1), 1118-1123 (1992).
49. Vogiagis D, Glare EM, Misajon A, Brown W, O'Brien PE. Cyclooxygenase-1 and an alternatively spliced mRNA in the rat stomach: effects of aging and ulcers. Am. J. Physiol. Gastrointest. Liver Physiol. 278(5), G820-G827 (2000).
50. Liu L, Turner JR, Yu Y et al. Differential expression of EGFR during early reparative phase of the gastric mucosa between young and aged rats. Am. J. Physiol. 275(5 Pt 1), G943-G950 (1998).
51. Majumdar AP. Regulation of gastrointestinal mucosal growth during aging. J Physiol. Pharmacol. 54(Suppl. 4), 143-154 (2003).
52. Lee M. Age-related changes in gastric blood flow in rats. Gerontology 42 (5), 289-293 (1996).
53. Bhala N, Newton JL. Upper gastrointestinal alarms in older people. Lancet 366(9490), 982-983 (2005).
54. Chow LW, Gertsch P, Poon RT, Branicki FJ. Risk factors for rebleeding and death from peptic ulcer in the very elderly. Br. J. Surg. 85(1), 121-124 (1998).
55. Jones JI, Hawkey CJ. Physiology and organ-related pathology of the elderly: stomach ulcers. Best Pract. Res. Clin. Gastroenterol. 15(6), 943-961 (2001).
56. Kemppainen H, Raiha I, Sourander L. Clinical presentation of peptic ulcer in the elderly. Gerontology 43(5), 283-289 (1997).
57. Seinela L. Ahvenainen J. Peptic ulcer in the very old patients. Gerontology 46(5), 271-275 (2060).
58. Van Kouwen MC, Drenth JP, Verhoeven HM, Bos LP, Engels LG. Upper gastrointestinal endoscopy in patients aged 85 years or more. ResuIts of a feasibility study in a district general hospital. Arch. Gerontol. Geriatr. 37(1), 45-50 (2003).
59. Pilotto A, Franceschi M, Leandro G et al. The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs. Aging Clin. Exp. Res. 15(6), 494-499 (2003).
60. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am. J. Epidemiol. 159(3), 252-258 (2004).
61. Azuma T, Suto H, Ito Y et al. Eradication of Helicobacter pylori infection induces an increase in body mass index. Aliment. Pharmacol. Ther. 16 (Suppl. 2 ), 240-244 (2002)
62. Fujiwara Y, Higuchi K, Arafa UA et al. Long-term effect of Helicobacter pylori eradication on quality of life, body mass index, and newly developed diseases in Japanese patients with peptic ulcer disease. Hepatogastroenterology 49(47), 1298-1302 (2002).
63. Kamada T, Hata J, Kusunoki H et al. Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. Dig. Liver Dis. 37(1), 39-43 (2005).
64. Chapman IM. Endocrinology of anorexia of ageing. Best Pract. Res. Clin. Endocrinol. Metab. 18(3), 437-452 (2004).
65. Morley JE. Anorexia, sarcopenia, and aging. Nutrition 17(7-8), 660-663 (2001).
66. Salles N, Menard A, Georges A et al. Effects of Helicobacter pylori infection on gut appetite pepticle (leptin, ghrelin) expression in elderly inpatients. J. Gerontol. A Biol. Sci. Med. Sci. 61(11), 1144-1150 (2006).
67. Konturek JW, Konturek SJ, Kwiecien N et al. Leptin in the control of gastric secretion and gut hormones in humans infected with Helicobacter pylori. Scand J Gastroentol. 36(11), 1148-1154 (2001).
68. Azuma T, Suto H, Ito Y et al. Gastric leptin and Helicobacter pylori infection. Gut 49(3). 324-329 (2001).
69. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo, H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402(6762), 656-660 (1999).
70. Nwokolo CU, Freshwater DA, O'Hare P, Randeva HS. Plasma ghrelin following cure of Helicobacter pylori. Gut 52(5), 637-640 (2003).
71. Granberg C, Mansikka A. Lehtonen OP et al. Diagnosis of Helicabacter pylori infection by using pyloriset EIA-G and EIA-A for detection of serum immunoglobulin G (IgG) and IgA antibodies. J. Clin. Microbiol. 31(6), 1450-1453 (1993).
72. Kosunen TU, Seppala K, Sarna S, Sipponen P. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 339(8798), 893-895 (1992).
73. Liston R, Pitt MA, Banerjee AK. IgG ELISA antibodies and detection of Helicobacter pylori in elderly patients. Lancet 347(8996), 269 (1996).
74. Burns EA. Effects of aging on immune function. J. Nutr. Health Aging 8 (1), 9-18 (2004).
75. Monteiro L, Bergey B, Gras N, Megraud F. Evaluation of the performance of the Helico Blot 2.1 as a tool to investigate the virulence properties of Helicobacter pylori. Clin. Microbiol. Infect. 8(10), 676-679 (2002).
76. Pilotto A, Rassu M, Bozzola L et al. Cytotoxin-associated gene A-positive Helicobacter pylori infection-in the elderly. Association with gastric atrophy and intestinal metaplasia. J. Clin. Gastroenterol. 26(1), 18-22 (1998).
77. Pilotto A, Franceschi M, Leandro G et al. Noninvasive diagnosis of Helicobacter pylori infection in older subjects: comparison of the C-13-urea breath test with serology. J. Gerontol. Ser. A Biol. Sci. Med. 55 (3), M163-M167 (2000).
78. 13C urea breath test in Japanese patients. Helicobacter 5(2), 98-103 (2000).
79. Vaira D, Malfertheiner P, Megraud F et al. Diagnosis of Heliocobacter pylori infection. with a new non-invasive antigen-based assay. HpSA European study group. Lancet 354(9172), 30-33 (1999).
80. Monteiro L, Gras N, Vidal R, Cabrita J, Megraud F. Detection of Helicobacter pylori DNA in human feces by PCR: DNA stability and removal of inhibitors. J. Microbiol. Methods 45(2), 89-94 (2001).
81. Abdalla AM, Sordillo EM, Hanzely Z et al. Insensitivity of the CLOtest for H. pylori, especially in the elderly. Gastroenterology 115(1), 243-244 (1998).
82. Price AB. The Sydney System: histological division. J. Gastroenterol. Hepatol. 6(3), 209-222 (1991).
83. Genta RM, Dixon MF. The Sydney System revisited: the Houston International, Gastritis Workshop. Am. J Gastroenterol. 90(7), 1039-1041 (1995).
84. Mégraud F. Diagnostic bactériologique standard de l'infection à Helicobacter pylori. In: Helicobacter pylori - Epidémiologie, Pathogénie, Diagnostic (Volume 1). Mégraud F, Lamouliatte H (Eds). Elsevier, Paris, France 249-266 (1996).
85. Oleastro M, Ménard A, Santos A et al. Real-time PCR assay for rapid and accurate detection of point mutations conferring resistance to clarithromycin in Helicobacter pylori. J. Clin. Microbiol. 41(1), 397-402 (2003).
86. Brock J, Sauaia A, Ahnen D et al. Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project. JAMA 286(16), 1985-1993 (2001).
87. Kokkola A, Sipponen P, Rautelin H et al. The effect of Helicobater pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment. Pharmacol. Ther. 16(3), 515-520 (2062).
88. Pilotto A, Franceschi M, Leandro G et al. Efficacy of 7 day lansoprazole-based triple. therapy for Helicobacter pylori infection in elderly patients. J. Gastroenterol. Hepatol. 14(5), 468-475 (1999).
89. Kountouras J, Zavos C, Chatzopoulos D. H pylori infection and reflux oesophagitis. Gut 53(6), 912 (2004).
90. Kountouras J, Zavos C, Chatzopoulos D, Katsinelos P Helicobacter pylori and gastro-oesophageal reflux disease. Lancet 368(9540), 986-987 (2006).
91. Pilotto A, Franceschi M, Leandro G et al. Influence of Helicobacter pylori infection on severity of oesophagitis and response to therapy in the elderly. Dig. Liver Dis. 34(5), 328-331 (2002).
92. Pilotto A, Perri F, Leandro G, Franceschi M. Effect of Helicobacter pylori eradication on the outcome of reflux esophagitis and chronic gastritis in the elderly. A randomized, multicenter, eight-month study. Gerontology 52(2), 99-106 (2006).
93. Pilotto A, Di Mario F, Franceschi M et al. Pantoprazole versus one-week Helicobacter pylori eradication therapy for the prevention of acute NSAID-related gastroduodenal clanwge in elderly subjects. Aliment. Pharmacol. Ther. 14(8), 1077-1082 (2000).
94. Chan FK, To KF, Wu JC et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients stardrig long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 359(9300), 9-13 (2002).
95. Lai KC, Lam SK, Chu KM et al. Lansoprazole reduces ulcer relapse after eradication of Helicobacter pylori in nonsteroidal anti-inflammatory drug users - a randomized trial. Aliment. Pharmacol. Ther. 18(8), 829-836 (2003).
96. Chan FK, Chung SC, Suen BY et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N. Engl. J. Med. 344(13), 967-973 (2001).
97. Suzuki H, Marshall BJ, Hibi T. Overview: Helicobacter pylori and extragastric disease. Int. J. Hematol. 84 (4). 291-300 (2006).
98. Pasceri V, Patti G, Cammarota G, Pristipino C, Richichi G, Di Sciascio G. Virulent strains of Helicobacter pylori and vascular diseases: a meta-analysis. Am. Heart J. 151(6), 1215-1222 (2006).
99. Kountouras J, Tsolaki M, Gavalas E et al. Relationship between Helicobacter pylori infection and Alzheimer's disease. Neurology 66(6), 938-940 (2006).
100. Sailes-Montaudon N, Parrot F, Balas D, Bouzigon E, Rainfray M, Emeriau JP. Prevalence and mechanisms of hyperhomocysteinemia in elderly hospitalized patients. J. Nutr. Health Aging 7(2), 111-116 (2003).
101. Sipponen P, Laxen F, Huotari K, Harkonen M. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand. J. Gastroenterol. 38(12), 1209-1216 (2003).
102. Santarelli L, Gabrielli M, Cremonini F et al. Atrophic gastritis as a cause of hyperhomocysteinaemia. Aliment. Pharmacol. Ther. 19(1), 107-111 (2004).
103. Haider AW, Wilson PW, Larson MG et al. The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study. J. Am. Coll. Cardiol. 40(8), 1408-1413 (2002).
104. Preusch MR, Grau AJ, Buggle F et al. Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori. Stroke 35 (8), 1800-1804 (2004).
105. Pilotto A, Malfertheiner P. Review article: an approach to Helicobacter pylori infection in the elderly. Aliment. Pharmacol. Ther. 16(4). 683-691 (2002).
106. Pilotto A, Franceschi M, Leandro G et al. Cure of Helicobacter pylori infection in elderly patients: comparison of low versus high doses of clarithromycin in combination with amoxicillin and pantoprazole. Aliment. Pharmacol. Ther. 15(7), 1031-1036 (2001).
107. Pilotto A, Rassu M, Leandro G, Franceschi M, Di Mario F. Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer. Dig. Liver Dis. 32 (9), 763-768 (2000).
108. Parsons HK, Carter MJ, Sanders DS, Winstanley T, Lobo AJ. Helicobacter pylori antimicrobial resistance in the United Kingdom: the effect of age, sex and socio-economic status. Aliment. Pharmacol. Ther. 15(9), 1473-1478 (2001).
109. Meyer JM, Silliman NP, Wang W et al. Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999. Ann. Intern. Med. 136(1), 13-24 (2002).
110. Cindoruk M, Erkan G, Karakan T, Dursun A, Unal S. Efficacy and safety of Saccharomyces beulardii in the 14-day triple anti-Helicobacter pylori therapy: a prospective randomized placebo-controlled double-blind study. Helicobacter 12 (4), 309-316 (2007).